Exclusively focused on translational aspects of drug delivery, this journal provides a unique forum for publication of high-quality research.
Drug Delivery and Translational Research publishes research focused on such topics as designing and developing novel drug delivery systems, with a focus on their application to disease conditions; preclinical and clinical data related to drug delivery systems; short-term and long-term biocompatibility of drug delivery systems, host response; biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering; image-guided drug therapy; nanomedicine; devices for drug delivery and drug/device combination products.
In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to activities of the Controlled Release Society.
Drug Delivery and Translational Research publishes six issues a year.
- Accepted by ISI in SCIE, Biosis Previews and Biological Abstracts
Explores the effect in different disease conditions of rationally developed, effective delivery systems
- Focuses on high-quality research on the development of novel drug delivery systems
- Presents full-length papers, communications, and reviews, editorials and more
- Maria Jose Alonso
- Publishing model
- Hybrid. Learn about publishing OA with us
- 2.664 (2019)
- Impact factor
- 3.041 (2019)
- Five year impact factor
- 57 days
- Submission to first decision
- 153 days
- Submission to acceptance
- 103,623 (2019)
Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer
Authors (first, second and last of 7)
Effect of surfactant concentration and sterilization process on intraocular pressure–lowering activity of Δ9-tetrahydrocannabinol-valine-hemisuccinate (NB1111) nanoemulsions
Authors (first, second and last of 9)
Authors (first, second and last of 5)
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
In this Inspirational Note, Dr. Marianne Ashford outlines how the field of drug delivery has evolved over the past decades and shares skills, capabilities and behaviors instrumental and critical for the success of next-generation medicines.
This article will be free to access until January 17, 2021.
Read the best article from the December 2020 issue:
This paper was selected by the Guest Editors and Main Editors as the best paper from the 22nd International Symposium on Microencapsulation. This article will be Free-to-Access until 2 January, 2021.
Here are the ten most cited papers published from 2018-2019 in Drug Delivery and Translational Research. Together they represent high-quality research published in DDTR on a wide range of topics as judged and cited by your peers. Discover them now!
Societies, partners and affiliations
About this journal
- Electronic ISSN
- Print ISSN
- Abstracted and indexed in
- Chemical Abstracts Service (CAS)
- EBSCO Discovery Service
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- OCLC WorldCat Discovery Service
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)